AI Article Synopsis

  • A multi-index nomogram prediction model was developed to assess clinically significant prostate cancer by integrating PI-RADS V2.1 scores, quantitative MRI parameters, and clinical factors in a study involving over 2000 patients.
  • The model's effectiveness was evaluated using various statistical methods, including AUC (Area Under the Curve), revealing high sensitivity and specificity, particularly with two models: one combining PI-RADS and PSAD, and another that added ADCmean.
  • Validation results indicated strong performance in predicting CSPCa across both internal and external cohorts, with no significant difference found between predicted and actual probabilities, supporting the model's reliability.

Article Abstract

Objective: To develop and validate a multi-index nomogram prediction model for clinically significant prostate cancer(CSPCa) by combining the PI-RADS V2.1, quantitative magnetic resonance imaging (MRI) parameters and clinical indicators.

Methods: A total of 1740 patients (75% in the derivation cohort and 25% in the internal validation cohort) and 342 patients (the external validation cohort) were retrospectively included in the MRI follow-up database of the First Affiliated Hospital of Kunming Medical University between January 2015 and April 2021,and Gejiu People's Hospital between January 2020 and December 2022.Important predictors of CSPCa in MRI-related quantitative parameters, PSA-derived indicators, and clinical indicators, such as age, were screened. The Net Reclassification Improvement Index(NRI),Integrated Discrimination Improvement Index(IDI), and clinical decision curve analysis (DCA) were calculated to compare the performances of the different models. Receiver operating characteristic(ROC) curves and clinical calibration curves were used to analyze and compare diagnostic effects.

Results: The AUC value, best cut-off value, specificity, sensitivity and accuracy of model 1(PI-RADS + PSAD) derivation cohort were 0.935, 0.304, 0.861, 0.895 and 0.872, respectively. The AUC values of the internal and external validation cohorts for model 1 were 0.956 and 0.955, respectively. The AUC value, best cut-off value, specificity, sensitivity and accuracy of model 2(PI-RADS +PSAD + ADCmean) derivation cohort were 0.939, 0.401, 0.895, 0.853 and 0.882, respectively. The AUC values of the internal and external validation cohorts for model 2 were 0.940 and 0.960,respectively. After adding the ADCmean to the model, the NRI(categorical), NRI(continuous) and IDI values were 0.0154, 0.3498 and 0.0222, respectively. There was no significant difference between the predicted probability and actual probability (p> 0.05).

Conclusion: Models 1 and 2 had reliable, efficient and visual predictive value for CSPCa. The ADCmean is an important predictive indicator.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620971PMC
http://dx.doi.org/10.3389/fonc.2024.1467793DOI Listing

Publication Analysis

Top Keywords

derivation cohort
12
external validation
12
nomogram prediction
8
prediction model
8
model clinically
8
clinically prostate
8
pi-rads v21
8
quantitative parameters
8
parameters clinical
8
clinical indicators
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!